Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma.
about
Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantationHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaTreatment of high-risk neuroblastoma with anti-GD2 antibodies.Retinoic acid postconsolidation therapy for high-risk neuroblastoma patients treated with autologous haematopoietic stem cell transplantation.Novel Platinum(II) compounds modulate insulin-degrading enzyme activity and induce cell death in neuroblastoma cells.
P2860
Q24186451-A121363C-C439-4F43-B05D-4A7EDE52CA76Q24186636-54E51738-2650-4D06-8356-2D3A257F7AA8Q24200296-7ED38CCD-BE33-460A-9889-8F346E86AD18Q24235309-BE32D21A-E349-40A8-A2A7-38C02B2346F6Q37820755-1652A382-78A0-418C-ADA4-1B6C2CD60820Q38608663-BAD433B5-E830-4B89-A33D-A853A7D50164Q38934781-C21F99F1-A5B5-45D2-9407-0276C3622AEA
P2860
Detection of minimal residual disease in bone marrow during or after therapy as a prognostic marker for high-risk neuroblastoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Detection of minimal residual ...... r for high-risk neuroblastoma.
@en
Detection of minimal residual ...... r for high-risk neuroblastoma.
@nl
type
label
Detection of minimal residual ...... r for high-risk neuroblastoma.
@en
Detection of minimal residual ...... r for high-risk neuroblastoma.
@nl
prefLabel
Detection of minimal residual ...... r for high-risk neuroblastoma.
@en
Detection of minimal residual ...... r for high-risk neuroblastoma.
@nl
P1476
Detection of minimal residual ...... r for high-risk neuroblastoma.
@en
P2093
Reynolds CP
P304
P356
10.1097/00043426-200103000-00005
P577
2001-03-01T00:00:00Z